TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Norovent AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,115
|
1,207
|
1,152 |
Financial expenses |
1
![]() |
1
|
0 |
Earnings before taxes |
78
|
77
|
107 |
Total assets |
432
|
418
|
385 |
Current assets |
284
|
253
|
247 |
Current liabilities |
168
|
251
![]() |
251 |
Equity capital |
185
|
148
|
127 |
- share capital |
9
|
10
![]() |
10 |
Employees (average) |
10
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
42.8%
|
35.4%
|
33.0% |
Turnover per employee |
121
|
96 | |
Profit as a percentage of turnover |
7.0%
|
6.4%
|
9.3% |
Return on assets (ROA) |
18.3%
|
18.7%
|
27.8% |
Current ratio |
169.0%
|
100.8%
|
98.4% |
Return on equity (ROE) |
42.2%
|
52.0%
|
84.3% |
Change turnover |
-15
|
115
|
-38 |
Change turnover % |
-1%
|
11%
|
-3% |
Chg. No. of employees |
-2
|
1 | |
Chg. No. of employees % |
-17%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.